Profhilo has become one of the most widely adopted skin remodelling treatments in aesthetic medicine. Unlike conventional dermal fillers or skin boosters, Profhilo operates on a fundamentally different principle: rather than filling or volumising, it remodels and biostimulates the skin from within. This guide covers everything practitioners need to know about Profhilo, from its unique formulation and mechanism of action to the BAP injection technique, treatment protocols, side effects, expected outcomes, and how it compares to other biostimulatory treatments.

What Is Profhilo?

Profhilo (manufactured by IBSA Farmaceutici Italia) is an injectable stabilised hybrid cooperative complexes (SHCC) of hyaluronic acid. It is not a dermal filler and not a conventional skin booster. Profhilo contains one of the highest concentrations of pure hyaluronic acid available in an injectable product at 64 mg/2 ml (32 mg/ml), combining high-molecular-weight HA (H-HA) and low-molecular-weight HA (L-HA) in a thermally bonded complex with no chemical cross-linking agents or additives.

The dual-weight HA formulation is what sets Profhilo apart. H-HA and L-HA are thermally bonded (not chemically cross-linked) into hybrid cooperative complexes that diffuse slowly through the dermis after injection, providing both immediate hydration and progressive biostimulation of collagen, elastin, and adipocyte growth factors.

Key product specifications:

  • HA concentration: 64 mg per 2 ml syringe (32 mg/ml)
  • H-HA: 32 mg (high molecular weight, 1,100-1,400 kDa)
  • L-HA: 32 mg (low molecular weight, 80-100 kDa)
  • No chemical cross-linking agents, no additives, no lidocaine
  • Regulatory status: CE-marked (Europe), not FDA-approved in the US

Licensed practitioners can order Profhilo H+L and the full Profhilo range via the Profhilo brand page at Bioresus.

Mechanism of Action

Profhilo’s thermally bonded SHCC technology produces a dual biostimulation effect that distinguishes it from both classic HA fillers and conventional skin boosters:

Immediate Effects (Hydration and Tissue Spreading)

  • The L-HA component disperses rapidly through the dermis after injection, providing immediate and widespread hydration
  • The H-HA component forms a depot at the injection site, releasing slowly to sustain hydration and provide structural support
  • The unique slow-spreading behaviour means that just 5 injection points per side of the face can treat the entire facial dermis

Progressive Biostimulation

  • Profhilo stimulates four types of skin cells: fibroblasts, keratinocytes, adipocytes, and macrophages
  • Fibroblast stimulation increases collagen type I, III, and IV production as well as elastin synthesis
  • Adipocyte stimulation supports the dermal-hypodermal interface and helps restore subtle volume in areas of fat atrophy
  • The net result is measurable improvement in skin laxity, elasticity, hydration, and overall skin quality over a 2-month period following the initial course

Clinical Indications

Primary Indications

  • Skin laxity and loss of elasticity: the primary indication. Profhilo addresses the loosening of skin texture that occurs with intrinsic aging and photoaging
  • Skin quality improvement: rough texture, dullness, crepey skin, enlarged pores
  • Dehydrated skin: patients with chronically dry, dull, or environmentally damaged skin
  • Early-to-moderate volume loss in areas of fat atrophy: mid-face, jawline, neck
  • Crepey skin on the neck, decolletage, hands, arms, knees, and abdomen (using Profhilo Body)

Treatment Areas

  • Face: full facial skin remodelling using the BAP (Bio Aesthetic Points) technique
  • Neck and decolletage: crepey skin, skin laxity, and horizontal neck lines
  • Hands: age-related skin thinning and visible tendon prominence
  • Body (using Profhilo Body): abdomen, inner arms, inner thighs, knees (areas of skin laxity)

Contraindications

  • Known hypersensitivity to hyaluronic acid or any component of the formulation
  • Active infection or inflammation in the treatment area
  • Pregnancy and breastfeeding
  • Autoimmune conditions affecting the skin
  • History of severe anaphylaxis
  • Patients on anticoagulants (relative contraindication; increased bruising risk)

Profhilo Dosage and Treatment Protocol

Standard Face Protocol

  • Two treatment sessions, 4 weeks apart, using the BAP technique
  • Each session uses one syringe (2 ml) of Profhilo H+L per treatment area
  • 5 injection points per side of the face (10 points total) following the defined BAP landmarks
  • Maintenance: one session every 6 months after the initial two-session course

Neck and Decolletage

  • One syringe (2 ml) per session; 2 sessions, 4 weeks apart
  • Injection points distributed across the neck and upper chest based on skin laxity assessment
  • Avoid the platysma and superficial cervical vessels

Hands

  • 0.5 ml per hand per session; 2 sessions, 4 weeks apart
  • Inject into the dorsal skin of each hand at 4-5 points per hand

The BAP Injection Technique (Face)

The Bio Aesthetic Points (BAP) technique is the defined injection protocol for Profhilo facial treatment. It was designed specifically to match the spreading behaviour of Profhilo’s SHCC formulation, delivering the product to 5 anatomical landmark points per side from which the HA diffuses to cover the full dermal plane.

BAP Landmarks (per side)

  • Point 1: Cheekbone (zygomatic arch) — the most superior lateral point
  • Point 2: Mid-cheek (malar eminence) — below the orbital rim at the lateral canthus vertical
  • Point 3: Pre-auricular area — lateral cheek, above the mandibular notch
  • Point 4: Chin/mandibular area — lateral chin, above the mandibular border
  • Point 5: Nasolabial fold base — medial to the corner of the mouth, above the mandible

Injection Technique

  • Use a 25-27G needle
  • Insert the needle to the deep dermis / subcutaneous junction using a retrograde technique
  • Deposit 0.2 ml bolus at each point (1 ml per side, 10 boluses total per session)
  • Gentle massage after each injection promotes product spreading and patient comfort
  • Aspiration is not routinely required given the low viscosity and injection depth, but vascular awareness and knowledge of anatomical danger zones is essential

Post-Injection Care

  • Mild swelling and small nodules at injection points are expected and typically resolve within 24-48 hours
  • Advise patients to avoid strenuous exercise, saunas, and excessive sun exposure for 24-48 hours
  • Gentle skincare and sun protection post-treatment
  • Do not massage vigorously after treatment, as this may displace product

Profhilo Before and After: Expected Outcomes

Setting realistic expectations is critical for patient satisfaction with Profhilo.

Timeline of Results

  • Immediately post-treatment: mild swelling, small injection point nodules, possible bruising. Slight glow from immediate hydration improvement
  • Week 1-2: Resolution of injection site reactions; patients notice improved skin hydration and a natural luminosity
  • Week 4-6: Skin texture noticeably smoother; improved elasticity measurable; subtle tightening of lax areas begins
  • Month 2-3: Peak biostimulatory results visible. Patients report meaningfully improved skin firmness, tone, and texture. Reduction in fine crepey skin, particularly in the neck and around the eyes
  • Month 6: Results plateau; maintenance session recommended to sustain improvements

Realistic Outcomes

  • Profhilo does not add significant volume or correct deep structural deficits — it is a skin quality treatment, not a volumiser
  • Results are most dramatic in patients with mild-to-moderate skin laxity and dehydration; patients with severe laxity or significant volume loss will need complementary treatments
  • Profhilo works exceptionally well in combination with dermal fillers (adding volume) and botulinum toxin (reducing dynamic lines)

Profhilo Side Effects and Safety

Common (Expected)

  • Small bruise-free papules at BAP injection points (visible for up to 48 hours)
  • Mild bruising, particularly in patients on aspirin or supplements
  • Mild swelling and erythema at injection points (resolves within hours to days)

Less Common

  • Prolonged nodules at injection sites (lasting beyond 1 week) — usually resolve spontaneously; avoid vigorous massage
  • Headache
  • Temporary flu-like symptoms (very rare)

Serious (Rare)

  • Vascular occlusion — rare due to low injection volumes and defined BAP points, but anatomical awareness and vascular safety protocols remain essential
  • Infection — extremely rare with proper aseptic technique
  • Hypersensitivity reactions — practitioners should be equipped to manage anaphylaxis

Profhilo vs Other Biostimulatory and Skin Booster Treatments

  • Profhilo vs conventional skin boosters (e.g., Restylane Vital, Juvederm Volite): Conventional skin boosters are primarily hydrating HA products. Profhilo’s SHCC technology goes beyond hydration to biostimulate collagen, elastin, and adipocyte growth factors — delivering structural skin remodelling over time rather than primarily a moisture effect.
  • Profhilo vs Polynucleotides (e.g., Rejuran): Both are biostimulatory treatments that improve skin quality at the cellular level. Polynucleotides such as Rejuran work via polynucleotide chains that bind cell receptors and stimulate DNA repair. Profhilo works via dual-weight HA biostimulation. They can be used complementarily.
  • Profhilo vs Sculptra: Sculptra (PLLA) stimulates collagen via a foreign body response and provides longer-lasting volumisation. Profhilo works faster, is more hydrating, and produces a softer, more natural result with no risk of nodule formation.
  • Profhilo vs Radiesse: Radiesse (calcium hydroxylapatite) adds immediate structural volume alongside collagen stimulation, whereas Profhilo remodels skin quality without volumising. Our Radiesse practitioner guide covers where each product fits in a combination plan.

Patient Selection and Counselling

Ideal Candidates

  • Adults aged 30-65 with mild-to-moderate skin laxity, dehydration, or crepey texture
  • Patients seeking a natural, gradual skin quality improvement without obvious volume addition
  • Patients wishing to improve the texture and condition of skin in the neck, decolletage, or hands
  • Patients who already have good facial structure but want to improve overall skin quality
  • Patients wanting to maintain the results of other treatments between sessions

Less Suitable Candidates

  • Patients with significant structural volume deficit requiring filler treatment (Profhilo alone will not address this)
  • Patients with severe skin laxity requiring a lifting procedure
  • Patients with unrealistic expectations about dramatic or immediate results

Key Counselling Points

  • Profhilo is not a filler and will not add visible volume or lift sagging tissue
  • The initial course requires two treatment sessions, 4 weeks apart
  • Results build gradually over 6-8 weeks following the first session
  • Maintenance is required every 6 months to sustain the biostimulatory effect
  • Profhilo is frequently combined with other treatments for comprehensive facial rejuvenation

Ordering Profhilo Wholesale

Licensed practitioners can order Profhilo H+L, Profhilo Body, and Profhilo Structura at wholesale prices from Bioresus. Browse the full skin booster and mesotherapy range for the complete selection. All products are sourced from authorised distributors and come with full documentation.

Conclusion

Profhilo represents a genuine advance in biostimulatory skin treatment. Its unique SHCC formulation, high HA concentration, and the simplicity of the BAP protocol make it one of the most effective and elegant tools available for addressing skin laxity, dehydration, and quality in the mid-to-late aging patient. For practitioners building a comprehensive injectable portfolio, Profhilo is a natural complement to dermal fillers and neurotoxins, addressing the skin quality dimension that volumisers alone cannot.